StockMacro
Menu

Haemonetics

$120.16 +80% in 6 monthsMarket cap $5.5B

HAE on XNYS, Health Care, Haemonetics Corporation, job postings

Measures activity, not value. Not investment advice.

Capital spending rose to $14.8M, 2.9 times a year earlier, as quarterly revenue grew 9.3% to $357.8M.

  • BadLast 12 months net income fell 38% to $103.9M

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 26 Sep 2026

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
3,009
Website
haemonetics.com
Listed
NYSE, US
Last results
5 Nov 2026
Next results
expected around 4 Feb 2027 (an estimate: a year ago it reported on 5 Feb 2026)
Revenue and net income per quarter. Quarter to 26 Sep 2026: revenue $357.8M, net income $46.3M.
Quarter to 1 Jan 2022: revenue $259.8M, net income $23.2MQuarter to 1 Jan 2022: revenue $259.8M, net income $23.2MQuarter to 2 Apr 2022: revenue –, net income $9.7MQuarter to 2 Jul 2022: revenue $261.5M, net income $19.9MQuarter to 2 Jul 2022: revenue $261.5M, net income $19.9MQuarter to 1 Oct 2022: revenue $297.5M, net income $33.2MQuarter to 1 Oct 2022: revenue $297.5M, net income $33.2MQuarter to 31 Dec 2022: revenue $305.3M, net income $32.9MQuarter to 31 Dec 2022: revenue $305.3M, net income $32.9MQuarter to 1 Apr 2023: revenue –, net income $29.4MQuarter to 1 Jul 2023: revenue $311.3M, net income $41.0MQuarter to 1 Jul 2023: revenue $311.3M, net income $41.0MQuarter to 30 Sep 2023: revenue $318.2M, net income $24.9MQuarter to 30 Sep 2023: revenue $318.2M, net income $24.9MQuarter to 30 Dec 2023: revenue $336.2M, net income $31.2MQuarter to 30 Dec 2023: revenue $336.2M, net income $31.2MQuarter to 30 Mar 2024: revenue $343.3M, net income $20.4MQuarter to 30 Mar 2024: revenue $343.3M, net income $20.4MQuarter to 29 Jun 2024: revenue $336.2M, net income $38.4MQuarter to 29 Jun 2024: revenue $336.2M, net income $38.4MQuarter to 28 Sep 2024: revenue $345.5M, net income $33.8MQuarter to 28 Sep 2024: revenue $345.5M, net income $33.8MQuarter to 28 Dec 2024: revenue $348.5M, net income $37.5MQuarter to 28 Dec 2024: revenue $348.5M, net income $37.5MQuarter to 29 Mar 2025: revenue $330.6M, net income $58.0MQuarter to 29 Mar 2025: revenue $330.6M, net income $58.0MQuarter to 28 Jun 2025: revenue $321.4M, net income $34.0MQuarter to 28 Jun 2025: revenue $321.4M, net income $34.0MQuarter to 27 Sep 2025: revenue $327.3M, net income $38.7MQuarter to 27 Sep 2025: revenue $327.3M, net income $38.7MQuarter to 27 Dec 2025: revenue $339.0M, net income $44.7MQuarter to 27 Dec 2025: revenue $339.0M, net income $44.7MQuarter to 28 Mar 2026: revenue $346.4M, net income -$20.1MQuarter to 28 Mar 2026: revenue $346.4M, net income -$20.1MQuarter to 27 Jun 2026: revenue $339.4M, net income $33.0MQuarter to 27 Jun 2026: revenue $339.4M, net income $33.0MQuarter to 26 Sep 2026: revenue $357.8M, net income $46.3MQuarter to 26 Sep 2026: revenue $357.8M, net income $46.3M
1 Jan 2022RevenueNet incomeNet losstallest bar $357.8M26 Sep 2026
See the numbers
Quarter toRevenueNet income
26 Sep 2026$357.8M$46.3M
27 Jun 2026$339.4M$33.0M
28 Mar 2026$346.4M-$20.1M
27 Dec 2025$339.0M$44.7M
27 Sep 2025$327.3M$38.7M
28 Jun 2025$321.4M$34.0M
29 Mar 2025$330.6M$58.0M
28 Dec 2024$348.5M$37.5M
28 Sep 2024$345.5M$33.8M
29 Jun 2024$336.2M$38.4M
30 Mar 2024$343.3M$20.4M
30 Dec 2023$336.2M$31.2M
30 Sep 2023$318.2M$24.9M
1 Jul 2023$311.3M$41.0M
1 Apr 2023–$29.4M
31 Dec 2022$305.3M$32.9M
1 Oct 2022$297.5M$33.2M
2 Jul 2022$261.5M$19.9M
2 Apr 2022–$9.7M
1 Jan 2022$259.8M$23.2M
Fundamentals, 12 months to 26 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.4B $1.3B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +4.1% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $103.9M $168.2M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $2.26 $3.42
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 59.6% 58.3% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 12.8% 18.3% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 7.5% 12.7% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 11.9% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $298.2M –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $260.7M $296.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $1.1B $1.2B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $875.9M $928.3M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 1.3 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $19.73
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 52.7 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 4.0 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 4.6 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 6.1 2.8

Latest = 12 months to 26 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
HaemoneticsHAE (this company) $5.5B52.74.0+4.1%7.5%
Merit Medical SystemsMMSI $5.1B31.63.1+9.1%9.9%
TeleflexTFX $6.4B21.02.8+21%13.5%
MiniMedMMED $4.5Bloss1.4–-9.6%
ICU MedicalICUI $4.3B71.52.0-5.9%2.8%
HeartflowHTFL $4.1Bloss17.2+47%-33.1%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$101K

bought $0, sold $101K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+8.9%

354 13F filers vs 325

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

49.1M shares held by 13F filers (30 Sep 2026) of 45.5M outstanding (30 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

7.9%

3.6M shares sold short (30 Oct 2026) of 45.5M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

6.3

3.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+5.0%

3.4M shares sold short in the report before, 3.6M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

80%

80% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 52%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+9.3%

$357.8M vs $327.3M (quarter ended 26 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+194%

$14.8M vs $5.0M (quarter ended 26 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$595K

the 12 months before: $263K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

5

5 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.0×

5 articles in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Capital spending $14.8M, 2.9× a year earlier

Price $120.16 on 20 Nov 2026, +60% over 12 months (12-month range $52.24 to $127.42)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $101K in the last 12 months (the 12 months before: $99K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 2 published in the last 12 months, 0% on the 12 months before.
Revenue per quarter. Revenue $357.8M in the latest quarter, +9.3% on a year earlier.
Capital spending per quarter. Capital spending $14.8M in the latest quarter, +194% on a year earlier.
Institutional holders (13F filers). 354 13F filers reported holding it in the latest 13F quarter, +24% on a year earlier.
Federal obligations. Federal obligations: $513K published in the last 12 months, +56% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
10 Nov 2026Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 14.8M vs usual 6.3M (2026-09-26); 2.9x the same period a year earlier
28 Jul 20268-K and other filingsDirector or officer change
1 May 20268-K and other filingsDirector or officer change
1 May 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 May 20258-K and other filingsRestructuring costs announced
3 Mar 20258-K and other filingsDirector or officer change
3 Jan 20258-K and other filingsDirector or officer change
3 Jan 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Oct 2024Sharp changeShort interest spike: short interest spike, 5.3M vs usual 2.2M (2024-10-15); 3.7x the same period a year earlier
15 Oct 2024Sharp changeShort interest spike: short interest spike, 5.4M vs usual 2.1M (2024-09-30); 3.2x the same period a year earlier
1 Oct 2024Sharp changeShort interest spike: short interest spike, 5.4M vs usual 2.0M (2024-09-13); 3.4x the same period a year earlier
17 Sep 2024Sharp changeShort interest spike: short interest spike, 6.1M vs usual 1.9M (2024-08-30); 3.8x the same period a year earlier
16 Sep 20248-K and other filingsDirector or officer change
16 Sep 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Aug 2024Sharp changeShort interest spike: short interest spike, 5.0M vs usual 1.8M (2024-08-15); 3.9x the same period a year earlier
13 Aug 2024Sharp changeShort interest spike: short interest spike, 4.8M vs usual 1.8M (2024-07-31); 3.4x the same period a year earlier
30 Jul 2024Sharp changeShort interest spike: short interest spike, 4.7M vs usual 1.8M (2024-07-15); 3.6x the same period a year earlier
16 Jul 2024Sharp changeShort interest spike: short interest spike, 4.2M vs usual 1.7M (2024-06-28); 3.0x the same period a year earlier
2 Jul 2024Sharp changeShort interest spike: short interest spike, 3.9M vs usual 1.7M (2024-06-14); 2.7x the same period a year earlier
18 Jun 2024Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.7M (2024-05-31); 2.5x the same period a year earlier
1 May 20248-K and other filingsA major agreement ended
7 Aug 20238-K and other filingsDirector or officer change
7 Aug 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Oct 20228-K and other filingsDirector or officer change
16 Aug 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 45.5M vs usual 12.8M (2022-07-02); 3.3x the same period a year earlier
8 Aug 20228-K and other filingsDirector or officer change
1 Aug 20228-K and other filingsA major agreement ended
16 Jun 20228-K and other filingsDirector or officer change
31 May 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 35.1M vs usual 11.1M (2022-04-02); 3.0x the same period a year earlier
25 May 20228-K and other filingsDirector or officer change
21 Mar 20228-K and other filingsDirector or officer change
21 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Feb 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 26.7M vs usual 11.1M (2022-01-01); 2.8x the same period a year earlier
Insider net buying (open market)
Month from 1 Apr 2022: -$11K published
Month from 1 May 2022: -$651K published
Month from 1 Jun 2022: -$122K published
Month from 1 Jul 2022: -$3K published
Month from 1 Aug 2022: -$591K published
Month from 1 Sep 2022: -$3.6M published
Month from 1 Oct 2022: -$20K published
Month from 1 Jan 2023: -$215K published
Month from 1 Jun 2023: -$415K published
Month from 1 Jul 2023: -$444K published
Month from 1 Sep 2023: -$1.1M published
Month from 1 May 2024: -$2.9M published
Month from 1 Jul 2024: -$592K published
Month from 1 Nov 2025: $99K published
Month from 1 Nov 2026: -$101K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 1 published
Quarter from 1 Jul 2022: 1 published
Quarter from 1 Apr 2023: 1 published
Quarter from 1 Jul 2023: 2 published
Quarter from 1 Apr 2024: 1 published
Quarter from 1 Jul 2024: 2 published
Quarter from 1 Jul 2025: 1 published
Quarter from 1 Oct 2025: 1 published
Quarter from 1 Jan 2026: 1 published
Quarter from 1 Apr 2026: 1 published
Revenue per quarter
Quarter ended 1 Jan 2022: $259.8M, +8.1% on a year earlier; public on 9 Feb 2022
Quarter ended 2 Jul 2022: $261.5M, +14% on a year earlier; public on 11 Aug 2022
Quarter ended 1 Oct 2022: $297.5M, +24% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $305.3M, +18% on a year earlier; public on 8 Feb 2023
Quarter ended 1 Jul 2023: $311.3M, +19% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $318.2M, +7.0% on a year earlier; public on 3 Nov 2023
Quarter ended 30 Dec 2023: $336.2M, +10% on a year earlier; public on 9 Feb 2024
Quarter ended 30 Mar 2024: $343.3M; public on 21 May 2024
Quarter ended 29 Jun 2024: $336.2M, +8.0% on a year earlier; public on 9 Aug 2024
Quarter ended 28 Sep 2024: $345.5M, +8.6% on a year earlier; public on 8 Nov 2024
Quarter ended 28 Dec 2024: $348.5M, +3.7% on a year earlier; public on 7 Feb 2025
Quarter ended 29 Mar 2025: $330.6M, -3.7% on a year earlier; public on 22 May 2025
Quarter ended 28 Jun 2025: $321.4M, -4.4% on a year earlier; public on 8 Aug 2025
Quarter ended 27 Sep 2025: $327.3M, -5.3% on a year earlier; public on 7 Nov 2025
Quarter ended 27 Dec 2025: $339.0M, -2.7% on a year earlier; public on 6 Feb 2026
Quarter ended 28 Mar 2026: $346.4M, +4.8% on a year earlier; public on 21 May 2026
Quarter ended 27 Jun 2026: $339.4M, +5.6% on a year earlier; public on 7 Aug 2026
Quarter ended 26 Sep 2026: $357.8M, +9.3% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 1 Jan 2022: $26.7M, +184% on a year earlier; public on 9 Feb 2022
Quarter ended 2 Apr 2022: $35.1M, +202% on a year earlier; public on 26 May 2022
Quarter ended 2 Jul 2022: $45.5M, +227% on a year earlier; public on 11 Aug 2022
Quarter ended 1 Oct 2022: $36.0M, +73% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $16.8M, -37% on a year earlier; public on 8 Feb 2023
Quarter ended 1 Apr 2023: $11.9M, -66% on a year earlier; public on 23 May 2023
Quarter ended 1 Jul 2023: $9.7M, -79% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $24.7M, -31% on a year earlier; public on 3 Nov 2023
Quarter ended 30 Dec 2023: $22.3M, +32% on a year earlier; public on 9 Feb 2024
Quarter ended 30 Mar 2024: $9.7M, -19% on a year earlier; public on 21 May 2024
Quarter ended 29 Jun 2024: $5.7M, -41% on a year earlier; public on 9 Aug 2024
Quarter ended 28 Jun 2025: $3.8M, -34% on a year earlier; public on 8 Aug 2025
Quarter ended 27 Sep 2025: $5.0M; public on 7 Nov 2025
Quarter ended 27 Dec 2025: $6.3M; public on 6 Feb 2026
Quarter ended 27 Jun 2026: $7.9M, +111% on a year earlier; public on 7 Aug 2026
Quarter ended 26 Sep 2026: $14.8M, +194% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 237; public on 14 Feb 2022
31 Mar 2022 report: 228; public on 16 May 2022
30 Jun 2022 report: 229; public on 15 Aug 2022
30 Sep 2022 report: 244; public on 14 Nov 2022
31 Dec 2022 report: 272; public on 14 Feb 2023
31 Mar 2023 report: 285; public on 15 May 2023
30 Jun 2023 report: 273; public on 14 Aug 2023
30 Sep 2023 report: 276; public on 14 Nov 2023
31 Dec 2023 report: 279; public on 14 Feb 2024
31 Mar 2024 report: 284; public on 15 May 2024
30 Jun 2024 report: 305; public on 14 Aug 2024
30 Sep 2024 report: 291; public on 14 Nov 2024
31 Dec 2024 report: 301; public on 14 Feb 2025
31 Mar 2025 report: 302; public on 15 May 2025
30 Jun 2025 report: 288; public on 14 Aug 2025
30 Sep 2025 report: 285; public on 14 Nov 2025
31 Dec 2025 report: 318; public on 17 Feb 2026
31 Mar 2026 report: 317; public on 15 May 2026
30 Jun 2026 report: 325; public on 14 Aug 2026
30 Sep 2026 report: 354; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: -$384 published
Month from 1 Dec 2021: $20K published
Month from 1 Jan 2022: $45K published
Month from 1 Feb 2022: $44K published
Month from 1 May 2022: $26K published
Month from 1 Jul 2022: $12K published
Month from 1 Sep 2022: -$14K published
Month from 1 Oct 2022: $100K published
Month from 1 Nov 2022: $218K published
Month from 1 Dec 2022: $10K published
Month from 1 Jan 2023: $32K published
Month from 1 Feb 2023: $80K published
Month from 1 Mar 2023: $70K published
Month from 1 Apr 2023: $854 published
Month from 1 May 2023: $3K published
Month from 1 Jun 2023: -$30 published
Month from 1 Jul 2023: $78K published
Month from 1 Aug 2023: $113K published
Month from 1 Oct 2023: $161K published
Month from 1 Nov 2023: $9K published
Month from 1 Dec 2023: $79K published
Month from 1 Jan 2024: $35K published
Month from 1 Mar 2024: -$111K published
Month from 1 Apr 2024: $23K published
Month from 1 May 2024: $10K published
Month from 1 Jun 2024: $48K published
Month from 1 Sep 2024: $12K published
Month from 1 Oct 2024: $130K published
Month from 1 Nov 2024: $0 published
Month from 1 Dec 2024: $4K published
Month from 1 Jan 2025: $47K published
Month from 1 Feb 2025: $35K published
Month from 1 Mar 2025: $4K published
Month from 1 May 2025: $41K published
Month from 1 Jun 2025: $46K published
Month from 1 Jul 2025: $4K published
Month from 1 Aug 2025: $0 published
Month from 1 Oct 2025: $8K published
Month from 1 Nov 2025: $139K published
Month from 1 Dec 2025: $0 published
Month from 1 Feb 2026: -$733 published
Month from 1 Mar 2026: $97K published
Month from 1 Apr 2026: $154K published
Month from 1 May 2026: $114K published
Month from 1 Jun 2026: $0 published
Month from 1 Jul 2026: $0 published
Month from 1 Aug 2026: $88K published
Month from 1 Sep 2026: $27K published
Month from 1 Oct 2026: $8K published
Month from 1 Nov 2026: $24K published

What is unusual now

  • Made public in the last 90 days: it spent $14.8M on capital projects in the quarter ended 26 Sep 2026, 2.9× the same quarter last year.
  • Quarterly capital spending jump: spent $14.8M on capital projects in the quarter ended 26 Sep 2026, 2.9× the same quarter last year Public on 10 Nov 2026.
  • Insider net buying (open market): Insiders sold a net $101K in the last 12 months (the 12 months before: $99K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 2 published in the last 12 months, 0% on the 12 months before.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 1 sale, $101K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
13 Nov 2026Farris Maryanne MaunsellVP, Chief Accounting OfficerSellafter exercising options836$120.99$101KForm 4
12 Nov 2025Mark W KrollDirectorBuy1,400$70.56$99KForm 4
29 Jul 2024Stewart W StrongPresident, Global HospitalSellplanned in advance (10b5-1)4,312$91.15$393KForm 4
15 Jul 2024Anila LingamneniEVP, Chief Technology OfficerSellplanned in advance (10b5-1)2,215$90.00$199KForm 4
29 May 2024Michelle L BasilEVP and General CounselSellplanned in advance (10b5-1)12,990$88.08$1.1MForm 4
29 May 2024Stewart W StrongPresident, Global HospitalSellplanned in advance (10b5-1)8,857$87.53$775KForm 4
21 May 2024Josep LlorensEVP, Global ManufacturingSellplanned in advance (10b5-1)1,809$94.96$172KForm 4
21 May 2024Stewart W StrongPresident, Global HospitalSellplanned in advance (10b5-1); after exercising options686$95.11$65KForm 4

354 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 63 opened a position, 28 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.6.0M13.1%$626.9M+44K+0.7%
Neuberger Berman Group LLC3.5M7.65%$366.7M-698K-17%
Vanguard Portfolio Management LLC2.5M5.49%$263.4M-45K-1.8%
Ariel Investments, LLC2.2M4.77%$228.9M+113K+5.5%
Vanguard Capital Management LLC2.0M4.49%$215.4M-14K-0.7%
AQR Capital Management LLC1.8M4.00%$189.5M-444K-20%
State Street Corp1.8M3.95%$189.4M-20K-1.1%
Citadel Advisors LLC1.7M3.65%$175.1M+153K+10%
T. Rowe Price Investment Management, Inc.1.4M3.13%+326K+30%
Goldman Sachs Group Inc1.4M3.00%$144.1M+322K+31%

Federal contracts

All 6 federal contracts

No new award in 12 months; the latest was signed 25 Sep 2014. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
25 Sep 2014Department of DefenseDepartment of the Army$1.2MACP-215 AUTOMATED CELL PROCESSUSAspending
30 Sep 2013Department of DefenseTricare Management Activity$17.1MLABORUSAspending
1 Jul 2011Department of DefenseDepartment of the Army$14.2Mup to $15.2MBASE PERIOD LABORUSAspending
30 Sep 2010Department of DefenseDefense Logistics Agency$226KFUSION CENTER SERVICESUSAspending
30 Sep 2008Department of DefenseDepartment of the Army$1.9MBASE YEAR LABORUSAspending
4 Mar 2008Department of DefenseDepartment of the Army$5.7Mup to $9.6MLABOR TO DESIGN AND DEVELOP A WEB BASEDUSAspending

Company events

All 55 company events

In 12 months: 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
28 Jul 2026Director or officer changeSame filing: shareholder vote results8-K
1 May 2026Director or officer change8-K
8 May 2025Restructuring costs announced8-K
3 Mar 2025Director or officer change8-K
3 Jan 2025Director or officer change8-K
16 Sep 2024Director or officer change8-K
29 May 2024Signed a major agreementSame filing: took on new debt, sold shares privately8-K
1 May 2024Signed a major agreement; A major agreement endedSame filing: took on new debt8-K

Reported lobbying spend: $40K in Q4 2013, $40K in Q3 2013. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Jan 2014EndedThe Conafay Group, LLCfor Haemonetics CorporationNot statedFiling
1 Nov 2012NewThe Conafay Group, LLCfor Haemonetics CorporationEducated staffers on importance of an equitable acquisition process for blood tracking software solutionsHealth issuesFiling
31 Oct 2012EndedFabiani & Companyfor Haemonetics CorporationEducated staffers on importance of an equitable acquisition process for blood tracking software solutionsHealth issuesFiling
1 Jul 2012NewFabiani & Companyfor Haemonetics CorporationEducated staffers on importance of an equitable acquisition process for blood tracking software solutions.Health issuesFiling

The 5 newest of 146 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 10 Nov 2026Financials change

    spent $14.8M on capital projects in the quarter ended 26 Sep 2026, 2.9× the same quarter last year.

    Same quarter last year: $5.0M; its normal quarter is $6.3M.

    See the evidence
    This period
    $14.8M (the quarter ended 26 Sep 2026)
    Normal quarter (median of 7 earlier)
    $6.3M
    Typical spread (median absolute deviation)
    $1.6M
    How far from its usual level
    +3.6
    Same quarter last year
    $5.0M
    History used
    6,300 days
    2023-12-30: $22.3M2024-03-30: $9.7M2024-06-29: $5.7M2025-06-28: $3.8M2025-09-27: $5.0M2025-12-27: $6.3M2026-06-27: $7.9M2026-09-26: $14.8M
    the quarter ended 26 Sep 20267 earlier quartersnormal: $6.3M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  2. 28 Jul 2026Filings record

    Director or officer change

  3. 1 May 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 1 May 2026Filings record

    Director or officer change

  5. 13 Nov 2025Insiders record

    KROLL MARK W (director) bought 1,400 shares of HAE ($98,784) (dated 12 Nov 2025)

  6. 8 May 2025Filings record

    Restructuring costs announced

  7. 3 Mar 2025Filings record

    Director or officer change

  8. 3 Jan 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  9. 3 Jan 2025Filings record

    Director or officer change

  10. 25 Oct 2024Short interest and volume change

    had 5.3M shares sold short in the 15 Oct 2024 report, 3.7× the same report last year.

    Same report last year: 1.4M; its normal report is 2.2M.

    See the evidence
    This period
    5.3M (the 15 Oct 2024 report)
    Normal report (median of 24 earlier)
    2.2M
    Typical spread (median absolute deviation)
    530K
    How far from its usual level
    +3.9
    Same report last year
    1.4M
    History used
    2,482 days
    2023-10-13: 1.4M2023-10-31: 1.7M2023-11-15: 1.8M2023-11-30: 1.7M2023-12-15: 1.7M2023-12-29: 1.8M2024-01-12: 1.7M2024-01-31: 1.7M2024-02-15: 1.8M2024-02-29: 2.0M2024-03-15: 2.2M2024-03-28: 2.0M2024-04-15: 2.2M2024-04-30: 2.6M2024-05-15: 2.5M2024-05-31: 3.3M2024-06-14: 3.9M2024-06-28: 4.2M2024-07-15: 4.7M2024-07-31: 4.8M2024-08-15: 5.0M2024-08-30: 6.1M2024-09-13: 5.4M2024-09-30: 5.4M2024-10-15: 5.3M
    the 15 Oct 2024 report24 earlier reportsnormal: 2.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 10 Oct 2024Short interest and volume change

    had 5.4M shares sold short in the 30 Sep 2024 report, 3.2× the same report last year.

    Same report last year: 1.7M; its normal report is 2.1M.

    See the evidence
    This period
    5.4M (the 30 Sep 2024 report)
    Normal report (median of 24 earlier)
    2.1M
    Typical spread (median absolute deviation)
    430K
    How far from its usual level
    +5.2
    Same report last year
    1.7M
    History used
    2,467 days
    2023-09-29: 1.7M2023-10-13: 1.4M2023-10-31: 1.7M2023-11-15: 1.8M2023-11-30: 1.7M2023-12-15: 1.7M2023-12-29: 1.8M2024-01-12: 1.7M2024-01-31: 1.7M2024-02-15: 1.8M2024-02-29: 2.0M2024-03-15: 2.2M2024-03-28: 2.0M2024-04-15: 2.2M2024-04-30: 2.6M2024-05-15: 2.5M2024-05-31: 3.3M2024-06-14: 3.9M2024-06-28: 4.2M2024-07-15: 4.7M2024-07-31: 4.8M2024-08-15: 5.0M2024-08-30: 6.1M2024-09-13: 5.4M2024-09-30: 5.4M
    the 30 Sep 2024 report24 earlier reportsnormal: 2.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 25 Sep 2024Short interest and volume change

    had 5.4M shares sold short in the 13 Sep 2024 report, 3.4× the same report last year.

    Same report last year: 1.6M; its normal report is 2.0M.

    See the evidence
    This period
    5.4M (the 13 Sep 2024 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    332K
    How far from its usual level
    +6.9
    Same report last year
    1.6M
    History used
    2,450 days
    2023-09-15: 1.6M2023-09-29: 1.7M2023-10-13: 1.4M2023-10-31: 1.7M2023-11-15: 1.8M2023-11-30: 1.7M2023-12-15: 1.7M2023-12-29: 1.8M2024-01-12: 1.7M2024-01-31: 1.7M2024-02-15: 1.8M2024-02-29: 2.0M2024-03-15: 2.2M2024-03-28: 2.0M2024-04-15: 2.2M2024-04-30: 2.6M2024-05-15: 2.5M2024-05-31: 3.3M2024-06-14: 3.9M2024-06-28: 4.2M2024-07-15: 4.7M2024-07-31: 4.8M2024-08-15: 5.0M2024-08-30: 6.1M2024-09-13: 5.4M
    the 13 Sep 2024 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 16 Sep 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 16 Sep 2024Filings record

    Director or officer change

  15. 12 Sep 2024Short interest and volume change

    had 6.1M shares sold short in the 30 Aug 2024 report, 3.8× the same report last year.

    Same report last year: 1.6M; its normal report is 1.9M.

    See the evidence
    This period
    6.1M (the 30 Aug 2024 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    288K
    How far from its usual level
    +9.8
    Same report last year
    1.6M
    History used
    2,436 days
    2023-08-31: 1.6M2023-09-15: 1.6M2023-09-29: 1.7M2023-10-13: 1.4M2023-10-31: 1.7M2023-11-15: 1.8M2023-11-30: 1.7M2023-12-15: 1.7M2023-12-29: 1.8M2024-01-12: 1.7M2024-01-31: 1.7M2024-02-15: 1.8M2024-02-29: 2.0M2024-03-15: 2.2M2024-03-28: 2.0M2024-04-15: 2.2M2024-04-30: 2.6M2024-05-15: 2.5M2024-05-31: 3.3M2024-06-14: 3.9M2024-06-28: 4.2M2024-07-15: 4.7M2024-07-31: 4.8M2024-08-15: 5.0M2024-08-30: 6.1M
    the 30 Aug 2024 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 27 Aug 2024Short interest and volume change

    had 5.0M shares sold short in the 15 Aug 2024 report, 3.9× the same report last year.

    Same report last year: 1.3M; its normal report is 1.8M.

    See the evidence
    This period
    5.0M (the 15 Aug 2024 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    240K
    How far from its usual level
    +9.0
    Same report last year
    1.3M
    History used
    2,421 days
    2023-08-15: 1.3M2023-08-31: 1.6M2023-09-15: 1.6M2023-09-29: 1.7M2023-10-13: 1.4M2023-10-31: 1.7M2023-11-15: 1.8M2023-11-30: 1.7M2023-12-15: 1.7M2023-12-29: 1.8M2024-01-12: 1.7M2024-01-31: 1.7M2024-02-15: 1.8M2024-02-29: 2.0M2024-03-15: 2.2M2024-03-28: 2.0M2024-04-15: 2.2M2024-04-30: 2.6M2024-05-15: 2.5M2024-05-31: 3.3M2024-06-14: 3.9M2024-06-28: 4.2M2024-07-15: 4.7M2024-07-31: 4.8M2024-08-15: 5.0M
    the 15 Aug 2024 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 10 Aug 2024Short interest and volume change

    had 4.8M shares sold short in the 31 Jul 2024 report, 3.4× the same report last year.

    Same report last year: 1.4M; its normal report is 1.8M.

    See the evidence
    This period
    4.8M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    227K
    How far from its usual level
    +8.9
    Same report last year
    1.4M
    History used
    2,406 days
    2023-07-31: 1.4M2023-08-15: 1.3M2023-08-31: 1.6M2023-09-15: 1.6M2023-09-29: 1.7M2023-10-13: 1.4M2023-10-31: 1.7M2023-11-15: 1.8M2023-11-30: 1.7M2023-12-15: 1.7M2023-12-29: 1.8M2024-01-12: 1.7M2024-01-31: 1.7M2024-02-15: 1.8M2024-02-29: 2.0M2024-03-15: 2.2M2024-03-28: 2.0M2024-04-15: 2.2M2024-04-30: 2.6M2024-05-15: 2.5M2024-05-31: 3.3M2024-06-14: 3.9M2024-06-28: 4.2M2024-07-15: 4.7M2024-07-31: 4.8M
    the 31 Jul 2024 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 25 Jul 2024Short interest and volume change

    had 4.7M shares sold short in the 15 Jul 2024 report, 3.6× the same report last year.

    Same report last year: 1.3M; its normal report is 1.8M.

    See the evidence
    This period
    4.7M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    247K
    How far from its usual level
    +8.0
    Same report last year
    1.3M
    History used
    2,390 days
    2023-07-14: 1.3M2023-07-31: 1.4M2023-08-15: 1.3M2023-08-31: 1.6M2023-09-15: 1.6M2023-09-29: 1.7M2023-10-13: 1.4M2023-10-31: 1.7M2023-11-15: 1.8M2023-11-30: 1.7M2023-12-15: 1.7M2023-12-29: 1.8M2024-01-12: 1.7M2024-01-31: 1.7M2024-02-15: 1.8M2024-02-29: 2.0M2024-03-15: 2.2M2024-03-28: 2.0M2024-04-15: 2.2M2024-04-30: 2.6M2024-05-15: 2.5M2024-05-31: 3.3M2024-06-14: 3.9M2024-06-28: 4.2M2024-07-15: 4.7M
    the 15 Jul 2024 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 11 Jul 2024Short interest and volume change

    had 4.2M shares sold short in the 28 Jun 2024 report, 3.0× the same report last year.

    Same report last year: 1.4M; its normal report is 1.7M.

    See the evidence
    This period
    4.2M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    270K
    How far from its usual level
    +6.3
    Same report last year
    1.4M
    History used
    2,373 days
    2023-06-30: 1.4M2023-07-14: 1.3M2023-07-31: 1.4M2023-08-15: 1.3M2023-08-31: 1.6M2023-09-15: 1.6M2023-09-29: 1.7M2023-10-13: 1.4M2023-10-31: 1.7M2023-11-15: 1.8M2023-11-30: 1.7M2023-12-15: 1.7M2023-12-29: 1.8M2024-01-12: 1.7M2024-01-31: 1.7M2024-02-15: 1.8M2024-02-29: 2.0M2024-03-15: 2.2M2024-03-28: 2.0M2024-04-15: 2.2M2024-04-30: 2.6M2024-05-15: 2.5M2024-05-31: 3.3M2024-06-14: 3.9M2024-06-28: 4.2M
    the 28 Jun 2024 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 27 Jun 2024Short interest and volume change

    had 3.9M shares sold short in the 14 Jun 2024 report, 2.7× the same report last year.

    Same report last year: 1.5M; its normal report is 1.7M.

    See the evidence
    This period
    3.9M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    247K
    How far from its usual level
    +6.0
    Same report last year
    1.5M
    History used
    2,359 days
    2023-06-15: 1.5M2023-06-30: 1.4M2023-07-14: 1.3M2023-07-31: 1.4M2023-08-15: 1.3M2023-08-31: 1.6M2023-09-15: 1.6M2023-09-29: 1.7M2023-10-13: 1.4M2023-10-31: 1.7M2023-11-15: 1.8M2023-11-30: 1.7M2023-12-15: 1.7M2023-12-29: 1.8M2024-01-12: 1.7M2024-01-31: 1.7M2024-02-15: 1.8M2024-02-29: 2.0M2024-03-15: 2.2M2024-03-28: 2.0M2024-04-15: 2.2M2024-04-30: 2.6M2024-05-15: 2.5M2024-05-31: 3.3M2024-06-14: 3.9M
    the 14 Jun 2024 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 12 Jun 2024Short interest and volume change

    had 3.3M shares sold short in the 31 May 2024 report, 2.5× the same report last year.

    Same report last year: 1.3M; its normal report is 1.7M.

    See the evidence
    This period
    3.3M (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    241K
    How far from its usual level
    +4.4
    Same report last year
    1.3M
    History used
    2,345 days
    2023-05-31: 1.3M2023-06-15: 1.5M2023-06-30: 1.4M2023-07-14: 1.3M2023-07-31: 1.4M2023-08-15: 1.3M2023-08-31: 1.6M2023-09-15: 1.6M2023-09-29: 1.7M2023-10-13: 1.4M2023-10-31: 1.7M2023-11-15: 1.8M2023-11-30: 1.7M2023-12-15: 1.7M2023-12-29: 1.8M2024-01-12: 1.7M2024-01-31: 1.7M2024-02-15: 1.8M2024-02-29: 2.0M2024-03-15: 2.2M2024-03-28: 2.0M2024-04-15: 2.2M2024-04-30: 2.6M2024-05-15: 2.5M2024-05-31: 3.3M
    the 31 May 2024 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 1 May 2024Filings record

    A major agreement ended

  23. 7 Aug 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  24. 7 Aug 2023Filings record

    Director or officer change

  25. 19 Oct 2022Filings record

    Director or officer change

  26. 16 Aug 2022Financials change

    spent $45.5M on capital projects in the quarter ended 2 Jul 2022, 3.3× the same quarter last year.

    Same quarter last year: $13.9M; its normal quarter is $12.8M.

    See the evidence
    This period
    $45.5M (the quarter ended 2 Jul 2022)
    Normal quarter (median of 8 earlier)
    $12.8M
    Typical spread (median absolute deviation)
    $4.8M
    How far from its usual level
    +4.6
    Same quarter last year
    $13.9M
    History used
    4,753 days
    2020-06-27: $7.7M2020-09-26: $8.3M2020-12-26: $9.4M2021-04-03: $11.6M2021-07-03: $13.9M2021-10-02: $20.8M2022-01-01: $26.7M2022-04-02: $35.1M2022-07-02: $45.5M
    the quarter ended 2 Jul 20228 earlier quartersnormal: $12.8M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  27. 8 Aug 2022Filings record

    Director or officer change

  28. 1 Aug 2022Filings record

    A major agreement ended

  29. 16 Jun 2022Filings record

    Director or officer change

  30. 31 May 2022Financials change

    spent $35.1M on capital projects in the quarter ended 2 Apr 2022, 3.0× the same quarter last year.

    Same quarter last year: $11.6M; its normal quarter is $11.1M.

    See the evidence
    This period
    $35.1M (the quarter ended 2 Apr 2022)
    Normal quarter (median of 8 earlier)
    $11.1M
    Typical spread (median absolute deviation)
    $2.8M
    How far from its usual level
    +5.8
    Same quarter last year
    $11.6M
    History used
    4,662 days
    2020-03-28: $10.6M2020-06-27: $7.7M2020-09-26: $8.3M2020-12-26: $9.4M2021-04-03: $11.6M2021-07-03: $13.9M2021-10-02: $20.8M2022-01-01: $26.7M2022-04-02: $35.1M
    the quarter ended 2 Apr 20228 earlier quartersnormal: $11.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  31. 25 May 2022Filings record

    Director or officer change

  32. 21 Mar 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 21 Mar 2022Filings record

    Director or officer change

  34. 15 Feb 2022Financials change

    spent $26.7M on capital projects in the quarter ended 1 Jan 2022, 2.8× the same quarter last year.

    Same quarter last year: $9.4M; its normal quarter is $11.1M.

    See the evidence
    This period
    $26.7M (the quarter ended 1 Jan 2022)
    Normal quarter (median of 8 earlier)
    $11.1M
    Typical spread (median absolute deviation)
    $2.8M
    How far from its usual level
    +3.8
    Same quarter last year
    $9.4M
    History used
    4,571 days
    2019-12-28: $20.4M2020-03-28: $10.6M2020-06-27: $7.7M2020-09-26: $8.3M2020-12-26: $9.4M2021-04-03: $11.6M2021-07-03: $13.9M2021-10-02: $20.8M2022-01-01: $26.7M
    the quarter ended 1 Jan 20228 earlier quartersnormal: $11.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  35. 16 Nov 2021Financials change

    spent $20.8M on capital projects in the quarter ended 2 Oct 2021, 2.5× the same quarter last year.

    Same quarter last year: $8.3M; its normal quarter is $10.1M.

    See the evidence
    This period
    $20.8M (the quarter ended 2 Oct 2021)
    Normal quarter (median of 8 earlier)
    $10.1M
    Typical spread (median absolute deviation)
    $1.6M
    How far from its usual level
    +4.4
    Same quarter last year
    $8.3M
    History used
    4,480 days
    2019-09-28: $9.5M2019-12-28: $20.4M2020-03-28: $10.6M2020-06-27: $7.7M2020-09-26: $8.3M2020-12-26: $9.4M2021-04-03: $11.6M2021-07-03: $13.9M2021-10-02: $20.8M
    the quarter ended 2 Oct 20218 earlier quartersnormal: $10.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  36. 9 Nov 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  37. 9 Nov 2021Filings record

    Director or officer change

  38. 27 Jul 2021Short interest and volume change

    had 2.3M shares sold short in the 15 Jul 2021 report, 2.9× the same report last year.

    Same report last year: 792K; its normal report is 1.2M.

    See the evidence
    This period
    2.3M (the 15 Jul 2021 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    207K
    How far from its usual level
    +3.8
    Same report last year
    792K
    History used
    1,294 days
    2020-07-15: 792K2020-07-31: 959K2020-08-14: 1.3M2020-08-31: 1.5M2020-09-15: 1.2M2020-09-30: 982K2020-10-15: 969K2020-10-30: 1.1M2020-11-13: 1.0M2020-11-30: 1.3M2020-12-15: 1.2M2020-12-31: 1.1M2021-01-15: 1.1M2021-01-29: 701K2021-02-12: 1.0M2021-02-26: 1.0M2021-03-15: 1.7M2021-03-31: 1.6M2021-04-15: 2.0M2021-04-30: 1.5M2021-05-14: 1.9M2021-05-28: 2.4M2021-06-15: 2.5M2021-06-30: 3.2M2021-07-15: 2.3M
    the 15 Jul 2021 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  39. 13 Jul 2021Short interest and volume change

    had 3.2M shares sold short in the 30 Jun 2021 report, 3.2× the same report last year.

    Same report last year: 976K; its normal report is 1.1M.

    See the evidence
    This period
    3.2M (the 30 Jun 2021 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    178K
    How far from its usual level
    +7.6
    Same report last year
    976K
    History used
    1,279 days
    2020-06-30: 976K2020-07-15: 792K2020-07-31: 959K2020-08-14: 1.3M2020-08-31: 1.5M2020-09-15: 1.2M2020-09-30: 982K2020-10-15: 969K2020-10-30: 1.1M2020-11-13: 1.0M2020-11-30: 1.3M2020-12-15: 1.2M2020-12-31: 1.1M2021-01-15: 1.1M2021-01-29: 701K2021-02-12: 1.0M2021-02-26: 1.0M2021-03-15: 1.7M2021-03-31: 1.6M2021-04-15: 2.0M2021-04-30: 1.5M2021-05-14: 1.9M2021-05-28: 2.4M2021-06-15: 2.5M2021-06-30: 3.2M
    the 30 Jun 2021 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  40. 26 Jun 2021Short interest and volume change

    had 2.5M shares sold short in the 15 Jun 2021 report, 1.8× the same report last year.

    Same report last year: 1.4M; its normal report is 1.1M.

    See the evidence
    This period
    2.5M (the 15 Jun 2021 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    178K
    How far from its usual level
    +5.2
    Same report last year
    1.4M
    History used
    1,264 days
    2020-06-15: 1.4M2020-06-30: 976K2020-07-15: 792K2020-07-31: 959K2020-08-14: 1.3M2020-08-31: 1.5M2020-09-15: 1.2M2020-09-30: 982K2020-10-15: 969K2020-10-30: 1.1M2020-11-13: 1.0M2020-11-30: 1.3M2020-12-15: 1.2M2020-12-31: 1.1M2021-01-15: 1.1M2021-01-29: 701K2021-02-12: 1.0M2021-02-26: 1.0M2021-03-15: 1.7M2021-03-31: 1.6M2021-04-15: 2.0M2021-04-30: 1.5M2021-05-14: 1.9M2021-05-28: 2.4M2021-06-15: 2.5M
    the 15 Jun 2021 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

Showing the newest 40 of 89 entries; narrow the window or the kind of data to see older ones.

Not listed: 289 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000313143
Ticker
HAE
Domain
haemonetics.com
Employer name
Haemonetics Corporation, haemonetics manufacturing inc sub of haemonetics (2 unverified)
Hq location
MA|BOSTON|02110 (1 unverified)
Lobbying client
haemonetics
Name
5D Information Management, Inc, Advanced Cooling Therapy, LLC, Arryx, Inc, Cardiva Medical, Inc and 29 more
Uei
RL22UNXMMYM3
Wikidata
Q16980281
Wikipedia
Haemonetics
  • DOL H-1B labor condition applications and PERM certifications79 data points8 Feb 2021 to 29 Jun 2026
  • Federal lobbying disclosures (LDA)4 records, 20 data points1 Jul 2012 to 31 Mar 2014
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)150 records11 Jan 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1231 data points29 Mar 2008 to 30 Oct 2026
  • SEC Form 4 insider transactions186 records, 396 data points8 Aug 2016 to 13 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards6 records, 3948 data points1 Oct 2007 to 12 Nov 2026
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026